BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yoshida N, Midorikawa Y, Kajiwara T, Yoshida N, Nakayama H, Sugitani M, Takayama T. Hepatocellular Carcinoma with Sarcomatoid Change without Anticancer Therapies. Case Rep Gastroenterol 2013;7:169-74. [PMID: 23626518 DOI: 10.1159/000350558] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Yugawa K, Yoshizumi T, Mano Y, Harada N, Itoh S, Ikegami T, Soejima Y, Fujita N, Kohashi K, Aishima S, Oda Y, Mori M. Primary intrahepatic cholangiocarcinoma with sarcomatous stroma: case report and review of the literature. Surg Case Rep 2018;4:138. [PMID: 30478801 DOI: 10.1186/s40792-018-0543-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Lu J, Zhang J, Xiong XZ, Li FY, Ye H, Cheng Y, Zhou RX, Lin YX, Cheng NS. Primary hepatic sarcomatoid carcinoma: clinical features and prognosis of 28 resected cases. J Cancer Res Clin Oncol. 2014;140:1027-1035. [PMID: 24647927 DOI: 10.1007/s00432-014-1641-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
3 Ge D, Luo Z, Mao R, Zhao H, Lv X, Zhao J, Zhou J, Huang Z, Zhang Y, Li Z, Bi X, Cai J. Development and Validation of a Nomogram-Based Prognostic Evaluation Model for Sarcomatoid Hepatocellular Carcinoma. Adv Ther 2020;37:3185-205. [PMID: 32436026 DOI: 10.1007/s12325-020-01357-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Wege H, Schulze K, von Felden J, Calderaro J, Reig M; rare liver tumors working group of the European Reference Network on Hepatological Diseases (ERN RARE-LIVER). Rare variants of primary liver cancer: Fibrolamellar, combined, and sarcomatoid hepatocellular carcinomas. Eur J Med Genet 2021;64:104313. [PMID: 34418585 DOI: 10.1016/j.ejmg.2021.104313] [Reference Citation Analysis]
5 Ji W, Xing Y, Ma J, Zhao Z, Xu H, Zheng S, Li W, Li X. Primary Liver Sarcomatoid Carcinoma: A Case Series and Literature Review. J Hepatocell Carcinoma 2021;8:1117-27. [PMID: 34522692 DOI: 10.2147/JHC.S325182] [Reference Citation Analysis]
6 Minami Y, Nishida N, Kudo M. Radiofrequency ablation of liver metastasis: potential impact on immune checkpoint inhibitor therapy. Eur Radiol. 2019;29:5045-5051. [PMID: 30963271 DOI: 10.1007/s00330-019-06189-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
7 Zhu SG, Li HB, Yuan ZN, Liu W, Yang Q, Cheng Y, Wang WJ, Wang GY, Li H. Achievement of complete response to nivolumab in a patient with advanced sarcomatoid hepatocellular carcinoma: A case report. World J Gastrointest Oncol 2020; 12(10): 1209-1215 [PMID: 33133387 DOI: 10.4251/wjgo.v12.i10.1209] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
8 Kan A, Guo RP. The prognosis of subsequent surgical treatment in patients with sarcomatoid carcinoma in the liver: A retrospective study. Int J Surg 2018;55:145-51. [PMID: 29860126 DOI: 10.1016/j.ijsu.2018.05.736] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
9 Liao SH, Su TH, Jeng YM, Liang PC, Chen DS, Chen CH, Kao JH. Clinical Manifestations and Outcomes of Patients with Sarcomatoid Hepatocellular Carcinoma. Hepatology. 2019;69:209-221. [PMID: 30014620 DOI: 10.1002/hep.30162] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 24.0] [Reference Citation Analysis]
10 Ohya K, Saitoh S, Fujiyama S, Kawamura Y, Sezaki H, Hosaka T, Akuta N, Kobayashi M, Kobayashi M, Suzuki F, Suzuki Y, Arase Y, Ikeda K, Kinowaki K, Fujii T, Kondo F, Kumada H. Primary liver carcinoma with sarcomatous changes: Analysis of 10 cases. Hepatol Res 2019;49:711-7. [DOI: 10.1111/hepr.13295] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Lee KB. Sarcomatoid hepatocellular carcinoma with mixed osteoclast-like giant cells and chondroid differentiation. Clin Mol Hepatol 2014;20:313-6. [PMID: 25320737 DOI: 10.3350/cmh.2014.20.3.313] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
12 Wang T, Kong J, Yang X, Shen S, Zhang M, Wang W. Clinical features of sarcomatoid change in patients with intrahepatic cholangiocarcinoma and prognosis after surgical liver resection: A Propensity Score Matching analysis. J Surg Oncol 2020;121:524-37. [PMID: 31867746 DOI: 10.1002/jso.25815] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
13 Bello HR, Mahdi ZK, Lui SK, Nandwana SB, Harri PA, Davarpanah AH. Hepatocellular Carcinoma With Atypical Imaging Features: Review of the Morphologic Hepatocellular Carcinoma Subtypes With Radiology-Pathology Correlation. J Magn Reson Imaging 2021. [PMID: 33682266 DOI: 10.1002/jmri.27553] [Reference Citation Analysis]
14 Mitra S, Gupta S, Dahiya D, Saikia UN. A Rare Case of Primary Sarcomatous Hepatocellular Carcinoma Without Previous Anticancer Therapy. J Clin Exp Hepatol 2017;7:378-84. [PMID: 29234205 DOI: 10.1016/j.jceh.2017.03.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]